Biogen Sues Bayer, Others Over Multiple Sclerosis Drug
Biogen Idec Inc. has accused pharmaceutical heavyweights Bayer AG, Novartis AG, Pfizer Inc. and Merck KGaA unit EMD Serono Inc. of infringing a patent for multiple sclerosis treatment Avonex, on the...To view the full article, register now.
Already a subscriber? Click here to view full article